Critical evaluation of mouse models used to study pain and loss of pain perception in diabetic neuropathy

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 4, 2012, Pages 188-190

  Bierhaus, A ^a   Nawroth, P P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

animal models; diabetes; neuropathy

Indexed keywords

GABAPENTIN; GLYOXALASE; GLYOXALASE 1; PREGABALIN; UNCLASSIFIED DRUG;

ANALGESIA; BLOOD FLOW; DIABETIC NEUROPATHY; DISEASE DURATION; FACIAL EXPRESSION; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; LATENT PERIOD; NERVE CONDUCTION; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PAIN; PHENOTYPE; PRIORITY JOURNAL; RATING SCALE; REVIEW; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE;

AGNOSIA; ANIMALS; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; EVALUATION STUDIES AS TOPIC; HUMANS; MICE; MICE, TRANSGENIC; PAIN; PAIN PERCEPTION;

EID: 84860255526     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1304567     Document Type: Review

References (14)

1. Tesfaye S, Boulton A J, Dyck P J et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care: 2010; 33 2285 2293
2. Obrosova I G. Diabetic painful and insensate neuropathy: pathogenesis and potential treatments. Neurotherapeutics: 2009; 6 638 647
3. Sullivan K A, Lentz S I, Roberts J L Jr et al. Criteria for creating and assessing mouse models of diabetic neuropathy. Curr Drug Targets: 2008; 9 3 13 (Pubitemid 351201677)
4. Mogil J S, Davis K D, Derbyshire S W. The necessity of animal models in pain research. Pain: 2010; 151 12 17
5. Dolgin E. Animalgesic effects. NatMed: 2010; 16 1237 1240
6. Langford D J, Crager S E, Shehzad Z et al. Social modulation of pain as evidence for empathy in mice. Science: 2006; 312 1967 1970 (Pubitemid 43993726)
7. Langford D J, Bailey A L, Chanda M L et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods: 2010; 7 447 449
8. Chesler E J, Ritchie J, Kokayeff A et al. Genotype-dependence of gabapentin and pregabalin sensitivity: the pharmacogenetic mediation of analgesia is specific to the type of pain being inhibited. Pain: 2003; 106 325 335 (Pubitemid 37505880)
9. Jack M M, Ryals J M, Wright D E. Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy. Diabetologia: 2011; 54 2174 2182
10. Jack M M, Ryals J M, Wright D E. Protection from diabetes-induced peripheral sensory neuropathy - A role of elevated glyoxalase I? Exp. Neurol: 2011; 10.1016/j.expneurol.2011.12.015
11. v1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy. In revision. 2012
12. Homs J, Ariza L, Pags G et al. Comparative study of peripheral neuropathy and nerve regeneration in NOD and ICR diabetic mice. Diabetes. J Peripher Nerv Syst: 2011; 16 213 227
13. Ii M, Nishimura H, Kusano K F et al. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy. Circulation: 2005; 112 93 102 (Pubitemid 40962574)
14. Sullivan K A, Hayes J M, Wiggin T D et al. Mouse models of diabetic neuropathy. Neurobiol Dis: 2007; 28 276 285 (Pubitemid 350116599)